Holt–Oram syndrome

From WikiMD's Food, Medicine & Wellness Encyclopedia

(Redirected from Holt Oram Syndrome)

Autosomal dominant - en

Holt–Oram syndrome is a rare genetic disorder that affects the bones of the arms and hands (the upper limbs) and may also cause heart problems. It is also known as "heart-hand syndrome" due to the combination of limb and cardiac defects.

Presentation[edit | edit source]

Individuals with Holt–Oram syndrome typically have abnormalities in the bones of the upper limbs, which can range from minor to severe. These abnormalities may include:

  • Shortened or missing bones in the arms or hands
  • Abnormalities in the thumb, such as a missing thumb or a thumb that looks like a finger
  • Limited movement or function of the upper limbs

In addition to limb abnormalities, individuals with Holt–Oram syndrome often have congenital heart defects. These can include:

Genetics[edit | edit source]

Holt–Oram syndrome is caused by mutations in the TBX5 gene, which is located on chromosome 12. The TBX5 gene provides instructions for making a protein that is involved in the development of the heart and upper limbs. The syndrome is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.

Diagnosis[edit | edit source]

Diagnosis of Holt–Oram syndrome is based on clinical evaluation, family history, and genetic testing. Imaging studies such as X-rays, echocardiograms, and MRIs may be used to assess the extent of limb and heart abnormalities.

Management[edit | edit source]

Management of Holt–Oram syndrome involves a multidisciplinary approach, including:

  • Orthopedic care for limb abnormalities
  • Cardiac care for heart defects
  • Genetic counseling for affected individuals and their families

Epidemiology[edit | edit source]

Holt–Oram syndrome is a rare condition, with an estimated prevalence of 1 in 100,000 live births. It affects males and females equally.

History[edit | edit source]

Holt–Oram syndrome was first described in 1960 by Mary Holt and Samuel Oram, who identified the association between upper limb abnormalities and congenital heart defects.

See also[edit | edit source]

References[edit | edit source]

External links[edit | edit source]

-



Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD